306 related articles for article (PubMed ID: 27503742)
21. Painful neuropathies: the emerging role of sodium channelopathies.
Brouwer BA; Merkies IS; Gerrits MM; Waxman SG; Hoeijmakers JG; Faber CG
J Peripher Nerv Syst; 2014 Jun; 19(2):53-65. PubMed ID: 25250524
[TBL] [Abstract][Full Text] [Related]
22. Painful Na-channelopathies: an expanding universe.
Waxman SG
Trends Mol Med; 2013 Jul; 19(7):406-9. PubMed ID: 23664154
[TBL] [Abstract][Full Text] [Related]
23. Cold-aggravated pain in humans caused by a hyperactive NaV1.9 channel mutant.
Leipold E; Hanson-Kahn A; Frick M; Gong P; Bernstein JA; Voigt M; Katona I; Oliver Goral R; Altmüller J; Nürnberg P; Weis J; Hübner CA; Heinemann SH; Kurth I
Nat Commun; 2015 Dec; 6():10049. PubMed ID: 26645915
[TBL] [Abstract][Full Text] [Related]
24. Functional profiles of SCN9A variants in dorsal root ganglion neurons and superior cervical ganglion neurons correlate with autonomic symptoms in small fibre neuropathy.
Han C; Hoeijmakers JG; Liu S; Gerrits MM; te Morsche RH; Lauria G; Dib-Hajj SD; Drenth JP; Faber CG; Merkies IS; Waxman SG
Brain; 2012 Sep; 135(Pt 9):2613-28. PubMed ID: 22826602
[TBL] [Abstract][Full Text] [Related]
25. Infantile Pain Episodes Associated with Novel Nav1.9 Mutations in Familial Episodic Pain Syndrome in Japanese Families.
Okuda H; Noguchi A; Kobayashi H; Kondo D; Harada KH; Youssefian S; Shioi H; Kabata R; Domon Y; Kubota K; Kitano Y; Takayama Y; Hitomi T; Ohno K; Saito Y; Asano T; Tominaga M; Takahashi T; Koizumi A
PLoS One; 2016; 11(5):e0154827. PubMed ID: 27224030
[TBL] [Abstract][Full Text] [Related]
26. Voltage-gated sodium channel mutations and painful neuropathy: Na(v)1.9 joins the family.
Bennett DL
Brain; 2014 Jun; 137(Pt 6):1574-6. PubMed ID: 24776971
[No Abstract] [Full Text] [Related]
27. Paroxysmal extreme pain disorder M1627K mutation in human Nav1.7 renders DRG neurons hyperexcitable.
Dib-Hajj SD; Estacion M; Jarecki BW; Tyrrell L; Fischer TZ; Lawden M; Cummins TR; Waxman SG
Mol Pain; 2008 Sep; 4():37. PubMed ID: 18803825
[TBL] [Abstract][Full Text] [Related]
28. Sodium channel NaV1.9 mutations associated with insensitivity to pain dampen neuronal excitability.
Huang J; Vanoye CG; Cutts A; Goldberg YP; Dib-Hajj SD; Cohen CJ; Waxman SG; George AL
J Clin Invest; 2017 Jun; 127(7):2805-2814. PubMed ID: 28530638
[TBL] [Abstract][Full Text] [Related]
29. Intra- and interfamily phenotypic diversity in pain syndromes associated with a gain-of-function variant of NaV1.7.
Estacion M; Han C; Choi JS; Hoeijmakers JG; Lauria G; Drenth JP; Gerrits MM; Dib-Hajj SD; Faber CG; Merkies IS; Waxman SG
Mol Pain; 2011 Dec; 7():92. PubMed ID: 22136189
[TBL] [Abstract][Full Text] [Related]
30. Differential effect of lacosamide on Nav1.7 variants from responsive and non-responsive patients with small fibre neuropathy.
Labau JIR; Estacion M; Tanaka BS; de Greef BTA; Hoeijmakers JGJ; Geerts M; Gerrits MM; Smeets HJM; Faber CG; Merkies ISJ; Lauria G; Dib-Hajj SD; Waxman SG
Brain; 2020 Mar; 143(3):771-782. PubMed ID: 32011655
[TBL] [Abstract][Full Text] [Related]
31. Gain-of-function mutation of a voltage-gated sodium channel Na
Tanaka BS; Nguyen PT; Zhou EY; Yang Y; Yarov-Yarovoy V; Dib-Hajj SD; Waxman SG
J Biol Chem; 2017 Jun; 292(22):9262-9272. PubMed ID: 28381558
[TBL] [Abstract][Full Text] [Related]
32. E44Q mutation in Na
Takahashi K; Ohba T; Okamoto Y; Noguchi A; Okuda H; Kobayashi H; Harada KH; Koizumi A; Ono K; Takahashi T
Heliyon; 2021 Jun; 7(6):e07396. PubMed ID: 34222704
[TBL] [Abstract][Full Text] [Related]
33. A Novel SCN9A Mutation (F826Y) in Primary Erythromelalgia Alters the Excitability of Nav1.7.
Wu B; Zhang Y; Tang H; Yang M; Long H; Shi G; Tang J; Shi X
Curr Mol Med; 2017; 17(6):450-457. PubMed ID: 28990532
[TBL] [Abstract][Full Text] [Related]
34. Loss-of-function of the voltage-gated sodium channel NaV1.5 (channelopathies) in patients with irritable bowel syndrome.
Beyder A; Mazzone A; Strege PR; Tester DJ; Saito YA; Bernard CE; Enders FT; Ek WE; Schmidt PT; Dlugosz A; Lindberg G; Karling P; Ohlsson B; Gazouli M; Nardone G; Cuomo R; Usai-Satta P; Galeazzi F; Neri M; Portincasa P; Bellini M; Barbara G; Camilleri M; Locke GR; Talley NJ; D'Amato M; Ackerman MJ; Farrugia G
Gastroenterology; 2014 Jun; 146(7):1659-1668. PubMed ID: 24613995
[TBL] [Abstract][Full Text] [Related]
35. The small fiber neuropathy NaV1.7 I228M mutation: impaired neurite integrity via bioenergetic and mitotoxic mechanisms, and protection by dexpramipexole.
Lee SI; Hoeijmakers JGJ; Faber CG; Merkies ISJ; Lauria G; Waxman SG
J Neurophysiol; 2020 Feb; 123(2):645-657. PubMed ID: 31851560
[TBL] [Abstract][Full Text] [Related]
36. Pain behavior in SCN9A (Nav1.7) and SCN10A (Nav1.8) mutant rodent models.
Xue Y; Chidiac C; Herault Y; Gaveriaux-Ruff C
Neurosci Lett; 2021 May; 753():135844. PubMed ID: 33775738
[TBL] [Abstract][Full Text] [Related]
37. Oxidation differentially modulates the recombinant voltage-gated Na(+) channel α-subunits Nav1.7 and Nav1.8.
Schlüter F; Leffler A
Brain Res; 2016 Oct; 1648(Pt A):127-135. PubMed ID: 27450927
[TBL] [Abstract][Full Text] [Related]
38. [Paroxysmal limb intolerable pain (infantile pain episodes associated with novel Nav1.9 mutations in familial episodic pain syndrome)].
Noguchi A; Takahashi T; Okuda H; Kobayashi H; Koizumi A
Nihon Rinsho; 2017 Apr; 75(4):641-651. PubMed ID: 30549873
[TBL] [Abstract][Full Text] [Related]
39. Network topology of NaV1.7 mutations in sodium channel-related painful disorders.
Kapetis D; Sassone J; Yang Y; Galbardi B; Xenakis MN; Westra RL; Szklarczyk R; Lindsey P; Faber CG; Gerrits M; Merkies IS; Dib-Hajj SD; Mantegazza M; Waxman SG; Lauria G;
BMC Syst Biol; 2017 Feb; 11(1):28. PubMed ID: 28235406
[TBL] [Abstract][Full Text] [Related]
40. Protein arginine methyltransferase 7 modulates neuronal excitability by interacting with NaV1.9.
Ma T; Li L; Chen R; Yang L; Sun H; Du S; Xu X; Cao Z; Zhang X; Zhang L; Shi X; Liu JY
Pain; 2022 Apr; 163(4):753-764. PubMed ID: 34326297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
